Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Fusidic acid, ocular application

Generic name
Fusidic acid, ocular application
Brand name
ATC Code
S01AA13

Pharmacokinetics in children

No studies have been carried out into the pharmacokinetic parameters of ocular applications of fusidic acid in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

Acute bacterial conjunctivitis
  • Ocular
    • 1 month up to 18 years
      • In both eyes: 1%: 1 drop(s)/dose twice daily.
    • Term neonate
      • In both eyes: 1%: 1 drop(s)/dose twice daily.
    • Premature neonates Gestational age ≥ 32 weeks
      • In both eyes: 1%: 1 drop(s)/dose twice daily.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

References

  1. Jackson WB, et al, Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops., Can J Ophthalmol, 2002, Jun;37(4), 228-37; discussion 237
  2. Normann EK, et al, Treatment of acute neonatal bacterial conjunctivitis: a comparison of fucidic acid to chloramphenicol eye drops, Acta Ophthalmol Scand, 2002, Apr;80(2), 183-7
  3. van Bijsterveld OP, et al, Fusidic acid in infections of the external eye, Infection, 1987, Jan-Feb;15(1), 16-9

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes